- Research works
- 50 ▲ 12% vs 2013–17
- Citations
- 2.2k 43.4 per fractional work
- Top-10% rate
- 12.1% record average 16.5%
- Open access
- 34% world 28%
Not ranked overall: Medac (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.2×. Every wedge is a field page.
- Immunology and Microbiology 4.2×
- Medicine 3.6×
- Economics, Econometrics and Finance 2.6×
- Mathematics 2.4×
- Biochemistry, Genetics and Molecular Biology 1.8×
- Decision Sciences 1.0×
- Health Professions 0.6×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Agricultural and Biological Sciences 0.3×
- Engineering 0.2×
- Psychology 0.2×
- Social Sciences 0.1×
Which keywords describe research at Medac (Germany)?
By fractional works in all years, weighted toward what it does more of than the world: Prognostic Factors, Chemotherapy, Monoclonal Antibodies, Immunotherapy, Hematopoietic Stem Cells, Clinical Trials, Minimal Residual Disease and Immunogenicity.
- Immunosuppression
- Bioanalytical Methods
- Insurance Markets
- Dental Students
- Career Choice
- Inhibitors
- Molecular Profiling
- Rheumatoid Arthritis
- Biopharmaceuticals
- Antibody Engineering
- Lymphoma
- Classification
- Bone Marrow Niche
- Autoantibodies
- Childhood Cancer
- Rituximab
- Immunogenicity
- Clinical Trials
- Immunotherapy
- Chemotherapy
- Prognostic Factors
- Monoclonal Antibodies
- Hematopoietic Stem Cells
- Minimal Residual Disease
- Inflammation
- Acute Lymphoblastic Leukemia
- Therapeutic Antibodies
- Mesenchymal Stem Cells
- Graft-versus-Host Disease
- Cytokines
- PET Imaging
- Biological Therapy
- Fc Receptors
- Genetic Pathogenesis
- Motivation
- Molecular Characterization
- Clinical Outcomes
- Health Care Spending
- Targeted Therapy
- Biosimilars
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Prognostic Factors4▲ 19×7 topics
- Chemotherapy4▲ 11×12 topics
- Monoclonal Antibodies3▲ 47×3 topics
- Immunotherapy3▲ 9.8×9 topics
- Hematopoietic Stem Cells3▲ 55×2 topics
- Clinical Trials3▲ 8.6×7 topics
- Minimal Residual Disease3▲ 79×2 topics
- Immunogenicity2▲ 99×3 topics
- Inflammation2▲ 2.1×10 topics
- Rituximab2▲ 30×3 topics
- Acute Lymphoblastic Leukemia2▲ 130×1 topic
- Childhood Cancer2▲ 130×1 topic
- Therapeutic Antibodies2▲ 34×2 topics
- Autoantibodies2▲ 18×3 topics
- Mesenchymal Stem Cells2▲ 35×2 topics
- Bone Marrow Niche2▲ 115×1 topic
- Graft-versus-Host Disease2▲ 115×1 topic
- Classification2▲ 10×2 topics
- Cytokines2▲ 13×2 topics
- Lymphoma2▲ 24×3 topics
- PET Imaging2▲ 17×3 topics
- Antibody Engineering2▲ 34×1 topic
- Biological Therapy2▲ 63×1 topic
- Biopharmaceuticals2▲ 51×3 topics
- Fc Receptors2▲ 34×1 topic
- Rheumatoid Arthritis2▲ 35×1 topic
- Genetic Pathogenesis2▲ 51×1 topic
- Molecular Profiling2▲ 26×1 topic
- Motivation2▲ 10×2 topics
- Inhibitors1▲ 40×3 topics
- Molecular Characterization1▲ 15×3 topics
- Career Choice1▲ 88×1 topic
- Clinical Outcomes1▲ 13×2 topics
- Dental Students1▲ 97×1 topic
- Health Care Spending1▲ 42×1 topic
- Insurance Markets1▲ 42×1 topic
- Targeted Therapy1▲ 12×3 topics
- Bioanalytical Methods1▲ 158×1 topic
- Biosimilars1▲ 158×1 topic
- Immunosuppression1▲ 21×3 topics
Which research topics does Medac (Germany) publish most on?
By volume in 2022–2025: Bladder and Urothelial Cancer Treatments, Hematopoietic Stem Cell Transplantation, Urinary and Genital Oncology Studies and Acute Lymphoblastic Leukemia research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Bladder and Urothelial Cancer Treatments Surgery 1 works
- 2 Hematopoietic Stem Cell Transplantation Hematology 0 works
- 3 Urinary and Genital Oncology Studies Surgery 0 works
- 4 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
- 5 Folate and B Vitamins Research Rheumatology 0 works
- 6 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
- 7 T-cell and Retrovirus Studies Immunology 0 works
- 8 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
- 9 Urological Disorders and Treatments Urology 0 works
- 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Medac (Germany)'s research output changed?
Output in 2018–2022 was 12% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Wedel
- University of Applied Sciences Wedel
- AstraZeneca (Germany)
- Selected Electronic Technologies (Germany)
- Photonamic (Germany)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.